Novo Nordisk moves to launch Wegovy tablet in China
Novo Nordisk plans to seek approval in China for an oral Wegovy weight-loss pill as competition with Eli…
Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to Accelerate
tablets pills medicine bottle NEW SIZE ©PXHere Novo Nordisk (NYSE:NVO) is seeing strong uptake of its oral Wegovy…
The Latest Ozempic Side Effect? It May Make You Less Violent
Topline GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent criminal behavior among current users,…
3 Ridiculously Cheap Healthcare Stocks to Buy in June
Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…
Novo Nordisk comeback stirs as Wegovy pill wins UK approval
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another…
Novo Nordisk shares retreat after ADA conference updates fail to excite investors (NVO)
chart down red arrow NEW SIZE ©Shutterstock Novo Nordisk (NYSE:NVO) shares fell 3% on Monday as investors digested…
Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?
Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
Why Canadians can now get cheaper generic Ozempic
Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to help reverse her…
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
The pharmaceutical industry is highly technical and incredibly competitive. That is on clear display right now in the…
GLP-1 drugs may have a beneficial effect across many types of cancer
By Nancy Lapid June 3 (Reuters) – A growing body of evidence suggests that popular GLP-1 drugs, widely…
Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily Covered
Eli Lilly’s Foundayo weight loss oral pill competes against Novo Nordisk’s oral Wegovy. (Photo by: Michael Siluk/UCG/Universal Images…
Brazil approves first generic semaglutide pen after Ozempic patent expiry
SAO PAULO, May 26 (Reuters) – Brazil’s health regulator Anvisa said on Tuesday it had approved EMS’s Ozivy,…